Amalgamated Bank Clovis Oncology, Inc. Transaction History

Amalgamated Bank

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.63 - $2.96 $11,607 - $54,535	-18,424 Closed	0 $0
Q1 2022 Jun 30, 2022	SELL	$1.43 - $3.14 $2,029 - $4,455	-1,419 Reduced 7.15%	18,424 $37,000
Q4 2021 Feb 15, 2022	SELL	$2.7 - $4.76 $521 - $918	-193 Reduced 0.96%	19,843 $54,000
Q3 2021 Oct 29, 2021	BUY	$4.06 - $5.8 $4,973 - $7,105	1,225 Added 6.51%	20,036 $89,000
Q2 2021 Aug 16, 2021	BUY	$5.02 - $7.05 $35,185 - $49,413	7,009 Added 59.39%	18,811 $109,000
Q1 2021 May 13, 2021	SELL	$4.81 - $10.34 $5,646 - $12,139	-1,174 Reduced 9.05%	11,802 $83,000
Q4 2020 Feb 12, 2021	BUY	$4.13 - $6.41 $239 - $371	58 Added 0.45%	12,976 $62,000
Q3 2020 Oct 30, 2020	BUY	$4.82 - $7.72 $6,728 - $10,777	1,396 Added 12.12%	12,918 $75,000
Q2 2020 Aug 10, 2020	BUY	$5.69 - $9.69 $65,560 - $111,648	11,522 New	11,522 $78,000
Q3 2018 Nov 14, 2018	SELL	$29.37 - $49.48 $213,901 - $360,362	-7,283 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$42.06 - $62.4 $59,136 - $87,734	1,406 Added 23.92%	7,283 $331,000
Q1 2018 May 22, 2018	SELL	$50.12 - $67.72 $5,212 - $7,042	-104 Reduced 1.74%	5,877 $310,000
Q4 2017 Feb 13, 2018	BUY	$57.69 - $84.58 $22,729 - $33,324	394 Added 7.05%	5,981 $407,000
Q3 2017 Nov 09, 2017	BUY	$67.17 - $84.81 $375,278 - $473,833	5,587	5,587 $460,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.